CAPTRUST Financial Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
CAPTRUST Financial Advisors's CLB Position: Q2 2026 in Review
CAPTRUST Financial Advisors reduced its Core Laboratories (CLB) stake by 0.16% in Q2 2026, selling an estimated $828 and leaving 36,695 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.
CAPTRUST Financial Advisors first reported a position in CLB in Q4 2017 and has held it in 27 quarters since. The position peaked at $997K in Q3 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- CAPTRUST Financial Advisors held 36,695 shares of Core Laboratories worth $427K as of Q2 2026.
- CAPTRUST Financial Advisors sold 58 Core Laboratories shares in Q2 2026, an estimated $828.
- Core Laboratories made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2288 holding.
- CAPTRUST Financial Advisors first reported a position in Core Laboratories in Q4 2017 and has held it in 27 quarters since.
- CAPTRUST Financial Advisors's Core Laboratories position peaked at $997K in Q3 2024.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.